Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes a method for treating, preventing, or repairing damage to heart tissue by administering fragments of a protein called thymosin beta 4 (for example, AcSDKP) or using agents that generate these fragments. The invention offers a way to protect and help regenerate cardiovascular tissue after injury.

Use CasesContent extracted from patent full text and abstract with AI.

• Treating heart attack patients to promote tissue repair and recovery
• Preventing cardiac tissue damage during high-risk surgeries
• Protecting heart tissue in patients with chronic heart conditions such as heart failure
• Promoting cardiovascular healing after injury or medical procedures like angioplasty

BenefitsContent extracted from patent full text and abstract with AI.

• Enhances regeneration and repair of damaged heart tissue
• May reduce the extent of damage after heart attacks or other cardiac events
• Can be used as a preventive therapy for at-risk patients
• Minimally invasive—administers therapeutic fragments rather than requiring surgical intervention

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

A method of treatment for promoting regeneration or repair a damaged cardiovascular tissue, or for preventing damage to cardiovascular tissue, includes administering to the tissue a damage-treating or -preventing fragment of thymosin beta 4 (Tbeta4), such as AcSDKP, or a stimulating agent that forms such a fragment of (Tbeta4).